Indications of Erdafitinib

Erdafitinib(Erdafitinib)Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma(mUC), which is susceptibleFGFR3 pan>or FGFR2 gene alteration that has progressed during or after at least one cycle of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

Tell your doctor if you have had eye or vision problems before taking this medication. Before starting treatment, patients may need to have a negative pregnancy test. Men and women taking erdafitinib should use effective contraception to prevent pregnancy. Erdafitinib may harm an unborn baby or cause birth defects if the mother or father is using this medicine. Continue using birth control for at least 1 month after the last dose. If a mother or father becomes pregnant while taking erdafitinib, tell the doctor right away. Do not breastfeed while taking this medicine, and at least1month after the last dose.

Sometimes it is unsafe to use certain drugs together. Some medicines can affect the blood levels of other medicines you use, which may increase side effects or make the medicine less effective. Tell your doctor about all other drugs, especially drugs that may change phosphate levels-Potassium phosphate supplements, vitaminDsupplements, antacids, enemas, or laxatives containing phosphates, and other drugs known to contain phosphates. Other drugs may affect erdafitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all the medicines you currently take and any medicines you start or stop using. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.